AQR Capital Management’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-86,478
Closed -$127K 2388
2022
Q2
$127K Sell
86,478
-371,192
-81% -$273K ﹤0.01% 2057
2022
Q1
$526K Buy
457,670
+439,427
+2,409% +$716K ﹤0.01% 1801
2021
Q4
$46K Buy
+18,243
New +$71.7K ﹤0.01% 2178
2020
Q4
Sell
-61,825
Closed -$738K 2290
2020
Q3
$738K Sell
61,825
-52,381
-46% -$702K ﹤0.01% 1567
2020
Q2
$1.83M Sell
114,206
-8,353
-7% -$146K ﹤0.01% 1193
2020
Q1
$1.9M Buy
122,559
+84,575
+223% +$1.82M ﹤0.01% 1093
2019
Q4
$934K Buy
37,984
+26,114
+220% +$388K ﹤0.01% 1534
2019
Q3
$122K Sell
11,870
-11,555
-49% -$146K ﹤0.01% 2066
2019
Q2
$294K Buy
+23,425
New +$301K ﹤0.01% 1884
2018
Q2
Sell
-14,894
Closed -$264K 2404
2018
Q1
$264K Sell
14,894
-12,980
-47% -$219K ﹤0.01% 2070
2017
Q4
$350K Sell
27,874
-4,818
-15% -$70K ﹤0.01% 2023
2017
Q3
$623K Buy
32,692
+6,808
+26% +$104K ﹤0.01% 1864
2017
Q2
$391K Buy
+25,884
New +$391K ﹤0.01% 1972

Other funds holding EPZM